Rest Of Asia Pacific Blood Collection Devices Market (2025-2030)
The Rest Of Asia Pacific Blood Collection Devices Market was valued at $142.7 Million in 2025 and projected to reach to $213 Million by 2030, representing a compound annual growth rate of 8.3%. Rest Of Asia Pacific represents a high-growth emerging market for blood collection devices, driven by expanding healthcare infrastructure and increasing diagnostic testing demand.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Asia Pacific Blood Collection Devices Market Trends and Insights
- Rest Of Asia Pacific represents a critical emerging market within the broader Asia Pacific region, driven by increasing healthcare infrastructure investments, rising diagnostic testing volumes, and growing awareness of blood safety standards.
- The region's expanding middle class and improving access to healthcare facilities are accelerating demand for advanced blood collection solutions. Rest Of Asia Pacific is witnessing accelerated adoption of safety-engineered devices and automated collection systems as healthcare providers prioritize occupational safety and operational efficiency.
- The market growth in Rest Of Asia Pacific is supported by government initiatives promoting preventive healthcare and blood donation programs.
- Rest Of Asia Pacific's 8.3% compound annual growth rate significantly outpaces global trends, reflecting the region's untapped potential and improving healthcare spending patterns through 2030..
Key Market Statistics
- CAGR (2025-2030) 8.3% CAGR
- Market Size, 2025 ~USD 142.7 Million
- Forecast, 2030 ~USD 213 Million
- Country Rest Of Asia Pacific
Rest Of Asia Pacific Blood Collection Devices Market Overview
Market Valuation Growth :
Rest Of Asia Pacific blood collection devices market valued at USD 142.7 million in 2025, with strong expansion trajectory reaching USD 213.0 million by 2030, representing significant investment opportunities in emerging economies.
Regional CAGR Performance :
Rest Of Asia Pacific demonstrates a robust 8.3% CAGR from 2025-2030, outpacing the global average of 7.4%, indicating accelerated adoption and market maturation in this critical emerging region.
Healthcare Infrastructure Development :
Increasing investments in diagnostic infrastructure across Rest Of Asia Pacific countries are driving demand for advanced blood collection devices, supported by government healthcare initiatives and private sector expansion.
Diagnostic Testing Volume Surge :
Rising diagnostic testing volumes in Rest Of Asia Pacific, fueled by growing disease prevalence, preventive healthcare awareness, and improved access to laboratory services, are creating sustained demand for collection devices.
Rest Of Asia Pacific Blood Collection Devices Market Dynamics
- Countries in this region are experiencing rapid urbanization and rising healthcare expenditure, creating favorable conditions for market expansion.
- The region's growing middle class and improved access to diagnostic services are accelerating adoption of modern blood collection technologies. The market outlook remains positive through 2030, with sustained growth expected from government healthcare initiatives, private laboratory expansion, and rising awareness of preventive healthcare.
- Manufacturers entering this market should focus on cost-effective solutions, local partnerships, and compliance with regional regulatory standards to capitalize on the emerging opportunities in Rest Of Asia Pacific..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Rest Of Asia Pacific blood collection devices market valued at USD 142.7 million in 2025, expanding to USD 213.0 million by 2030 at 8.3% CAGR
- Rest Of Asia Pacific demonstrates higher growth momentum than global average, driven by emerging healthcare infrastructure and diagnostic demand
- Rest Of Asia Pacific adoption of safety-engineered and automated collection devices accelerating due to occupational safety regulations and efficiency requirements
- Rest Of Asia Pacific market expansion supported by government healthcare initiatives, rising blood donation awareness, and improving middle-class healthcare access
Blood Collection Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PLASMA/WHOLE BLOOD TUBES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.4% from 2025 to 2030 |
| Largest Segment | MANUAL BLOOD COLLECTION (Method) |
| Market Size Base Year (Billions) | ~USD 9.11 (2025) |
| Revenue Forecast (Billions) | ~USD 13.02 (2030) |
| Segments Covered | Product, Type, System Type, Method, Application, End User |
Rest Of Asia Pacific Blood Collection Devices Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Blood Bags
- Blood Collection Systems/ Monitors
- Blood Collection Tubes
- Lancets
- Needle & Syringes
By Type
- Coagulation Tubes
- Edta Tubes
- Esr Tubes
- Glucose Tubes
- Heparin Tubes
- Plasma/Whole Blood Tubes
- Serum Tubes
By System Type
- Non-Vacuum Type
- Vacuum Type
By Method
- Automated Blood Collection
- Manual Blood Collection
By Application
- Diagnostic Applications
- Therapeutic Applications
By End User
- Blood Banks
- Diagnostic & Pathology Labs
- Hospitals, Ambulatory Surgical Centers, And Nursing Homes
- Other End Users
Target Audience
- Medical Device Manufacturers : Manufacturers seeking to expand into Rest Of Asia Pacific need detailed market sizing, growth forecasts, and competitive intelligence to develop targeted product strategies and resource allocation plans.
- Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in Rest Of Asia Pacific healthcare require quantified market data, growth trajectories, and regional dynamics to assess portfolio companies and acquisition targets.
- Diagnostic Laboratory Operators : Laboratory chains and diagnostic service providers in Rest Of Asia Pacific need market insights to optimize procurement strategies, forecast equipment demand, and plan facility expansion initiatives.
- Healthcare Consultants : Consulting firms advising healthcare clients in Rest Of Asia Pacific require regional market intelligence to develop strategic recommendations, competitive analyses, and market entry strategies.
- Government & Healthcare Policymakers : Regional health authorities and policymakers need market data to inform healthcare infrastructure investments, procurement policies, and regulatory frameworks for blood collection device standards.
Key Companies in the Rest Of Asia Pacific Blood Collection Devices Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Turnkey automation systems (design, build, commissioning),Pre- and post-automation services,Software and digital solutions, |
| ABBOTT LABORATORIES | United States | Public Company | Medical Devices (cardiovascular, diabetes care, neuromodulation),Diagnostic Products (lab, rapid, molecular, point-of-care),Nutritional Products (pediatric, adult, infant formula), |
| NOLATO | Sweden | Public Company | Medical technology components and systems,Pharmaceutical and primary plastic packaging,EMC shielding and thermal management (Compatherm, Compashield, Trishield, MIL SPEC), |
| QIAGEN NV | Netherlands | Public Company | Sample technology consumables and instruments,Immune response (TB IGRA and transplant/viral load assays),Oncology and sexual & reproductive health assays, |
| DANAHER CORPORATION | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (research tools and genomic medicine inputs),Diagnostics (clinical instruments and consumables), |
| GRIFOLS, S.A. | Spain | Public Company | Biopharma (plasma-derived medicines),Diagnostic,Bio Supplies, |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion devices (syringes, catheters, IV sets),Pharmaceutical packaging (glass vials, ampoules, components), |
| HAEMONETICS CORPORATION | United States | Public Company | Plasma (NexSys PCS, NexLynk DMS, Donor360 and related disposables),Blood Center (whole blood and component collection, software),Hospital Hemostasis & Autotransfusion (TEG 6s, TEG Manager, Cell Saver Elite+), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & hardware, |
| CARDINAL HEALTH | United States | Public Company | Branded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Cardinal-branded and National Brands), |
| RETRACTABLE TECHNOLOGIES, INC. | United States | Public Company | VanishPoint safety syringes (insulin, tuberculin, allergy antigen),Blood collection sets and tube holders,IV safety catheters and Patient Safe syringes/Luer Caps, |
| AB MEDICAL CO., LTD. | Ireland | Public Company | Cardiovascular Portfolio,Medical Surgical Portfolio,Neuroscience Portfolio, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 with 7,000 employees. The company specializes in automation and tooling systems for industrial applications.
ABBOTT LABORATORIES
Abbott Laboratories is a major American public pharmaceutical and healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, diagnostics, and medical devices globally.
NOLATO
Nolato is a Swedish public company founded in 1938 with 5,607 employees. The company manufactures plastic components and solutions for medical, healthcare, and industrial applications.
QIAGEN NV
QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics, life sciences, and sample preparation technologies.
DANAHER CORPORATION
Danaher Corporation is a major American public conglomerate founded in 1969 with 59,000 employees. The company operates across multiple sectors including diagnostics, life sciences, and environmental solutions.
GRIFOLS, S.A.
Grifols, S.A. is a Spanish public company founded in 1909 with 25,000 employees. The company develops, manufactures, and distributes plasma-derived medicines and diagnostic solutions.
NIPRO CORPORATION
Nipro Corporation is a Japanese public company founded in 1954. The company manufactures medical devices, pharmaceuticals, and healthcare products.
HAEMONETICS CORPORATION
Haemonetics Corporation is an American public company founded in 1971 with 3,009 employees. The company develops and manufactures blood management and diagnostic solutions.
ICU MEDICAL, INC.
ICU Medical, Inc is an American public company founded in 1984 with 13,000 employees. The company manufactures infusion therapy and critical care medical devices.
CARDINAL HEALTH
Cardinal Health is an American public company founded in 1979 with 55,392 employees. The company is a leading distributor of pharmaceuticals, medical supplies, and healthcare services.
RETRACTABLE TECHNOLOGIES, INC.
Retractable Technologies, Inc is an American public company founded in 1994 with 198 employees. The company manufactures safety-engineered medical devices, including retractable syringes and needles.
AB MEDICAL CO., LTD.
AB Medical Co., Ltd is an Irish public company founded in 1949 with 95,000 employees. The company develops and manufactures medical devices and healthcare solutions.
Reasons to Buy this Report
- Market Entry Strategy : Comprehensive analysis of Rest Of Asia Pacific market dynamics enables informed market entry decisions, identifying high-potential countries and optimal timing for product launches in this rapidly growing region.
- Competitive Positioning : Detailed insights into Rest Of Asia Pacific competitive landscape, local players, and market gaps help manufacturers differentiate offerings and establish strong market presence ahead of competitors.
- Growth Opportunity Identification : Specific data on Rest Of Asia Pacific growth drivers—healthcare investments, diagnostic volume trends, and regulatory environment—enables identification of high-ROI business opportunities and expansion strategies.
- Investment Decision Support : Quantified market projections and regional CAGR analysis provide investors with evidence-based insights for capital allocation decisions in Rest Of Asia Pacific healthcare sector.
- Regulatory & Compliance Insights : Understanding Rest Of Asia Pacific-specific regulatory requirements, standards, and compliance pathways reduces market entry risks and accelerates product commercialization timelines.
Frequently asked questions
What is the current market size of blood collection devices in Rest Of Asia Pacific?
Rest Of Asia Pacific blood collection devices market is valued at USD 142.7 million in 2025 and is projected to reach USD 213.0 million by 2030.
What is the growth rate for blood collection devices in Rest Of Asia Pacific?
Rest Of Asia Pacific blood collection devices market is growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2030.
What factors are driving growth in Rest Of Asia Pacific blood collection devices market?
Rest Of Asia Pacific market growth is driven by expanding healthcare infrastructure, increasing diagnostic testing volumes, safety-engineered device adoption, government healthcare initiatives, and rising blood donation awareness.
How does Rest Of Asia Pacific market growth compare to global trends?
Rest Of Asia Pacific's 8.3% CAGR significantly outpaces the global market CAGR of 7.4%, reflecting the region's emerging market potential and improving healthcare spending.
What types of blood collection devices are in demand in Rest Of Asia Pacific?
Rest Of Asia Pacific shows increasing demand for safety-engineered devices, automated collection systems, and advanced phlebotomy solutions that prioritize occupational safety and operational efficiency.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global blood collection devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the blood collection devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Blood collection is the process of acquiring blood samples from patients for diagnostic and therapeutic purposes. It is an integral part of the diagnosis and blood group typing process in hospitals and blood bank centers. The blood collection devices market covers the products used to collect blood from patients/donors.
Stakeholders
- Healthcare Service Providers (Hospitals and Pathology Centers)
- Blood Collection Product Manufacturers
- Blood Banks
- Non-governmental Organizations (NGOs) and Government Organizations Associated with Blood Collection
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, and segment the global blood collection devices market by product, method, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global blood collection devices market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of market segments with respect to five major regional segments: North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their market positions and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the blood collection devices market
Get the Full Blood Collection Devices Market Report
Full forecast, segment splits, and company analysis for all Blood Collection Devices Market.
- China Blood Collection Devices Market
- India Blood Collection Devices Market
- Australia Blood Collection Devices Market
- Rest Of Europe Blood Collection Devices Market
- Canada Blood Collection Devices Market
- US Blood Collection Devices Market
- Germany Blood Collection Devices Market
- France Blood Collection Devices Market
- UK Blood Collection Devices Market
- Italy Blood Collection Devices Market
- Spain Blood Collection Devices Market
- Japan Blood Collection Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
